NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Saku Biosciences

Saku Biosciences

Private
Los Angeles, CaliforniaHealthcare & Life Scienceshttps://www.sakubio.com/

Last Round

Pre Seed

May 18, 2026

Total Funding Raised

$200,000

Company Overview

Saku Biosciences is a biotechnology company that develops high-throughput screening technologies, including its proprietary PicoShell platform, to accelerate strain engineering and improve biomanufacturing economics.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Non-AI

Keywords

strain engineeringhigh-throughput screeningcell line developmentbiomanufacturingPicoShellsynthetic biologysynbiomicrobial screeninghost cell engineeringbiotech servicescontract research organizationCROfermentation optimizationhydrogel encapsulationbioprocess development

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Saku Biosciences Comps

Public and private peers based on sector, stage, and business model.

Saku Biosciences comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Saku Biosciences Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Pre SeedMay 18, 2026

Key People

Founding team and executive leadership

John Alden

Chief Business Officer, Co-Founder

Founding Team

Mark van Zee

Co-founder and CEO

Founding Team

Saku Biosciences Investors

Notable investors and investment history

Saku Biosciences investors
InvestorRounds
Capital FactoryAccelerator
UCLA Anderson Venture AcceleratorAccelerator
Big Idea VenturesPre Seed

Saku Biosciences Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Saku Biosciences Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Saku Biosciences's valuation, stock price, and market status.

Firmographic Details

HeadquartersLos Angeles, California
Employee Range8
Year Founded2024
Last FundingMay 18, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.